FDA approves Eli Lilly’s tirzepatide for obesity, paving way for even wider use of blockbuster drug

Read Time:6 Second

The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

A group of Latino executives are starting an organization to promote Hispanic advancement within the sports industry.

Chipotle Mexican Grill, Wingstop and Sweetgreen all beat Wall Street's estimates for their quarterly same-store sales growth.

Ford named the former CFO of electric-vehicle startup Lucid to replace its current CFO, who is being promoted to closely...

For some it can be challenging to juggle raising a family while also working full time. Just Capital identified the...

The potential new offering comes at a time when low-income consumers are beginning to pull back on spending, particularly at...

Shares of the salad chain surged 35% Friday after the company beat Wall Street's forecast for first-quarter results.